Laugh at the cold, or cry? (Minneapolis-St. Paul Star Tribune)
Sometimes it's a matter of what you're used to and how your body - and mind - react.
Read more...
Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First Ever In Vivo Efficacy Data for a ... (Business Wire via Yahoo! Finance)
CAMBRIDGE, Mass. & CARLSBAD, Calif.----Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. formed to discover, develop, and commercialize microRNA-based therapeutics, announced today the publication of new research in the journal Nature on the role of a microRNA, known as miR-21, in heart failure.
Read more...
Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First Ever In Vivo Efficacy Data for a ... (Centre Daily Times)
Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA-based therapeutics, announced today the publication of new research in the journal Nature on the role of a microRNA, known as miR-21, in heart failure (1) . The new findings demonstrated that miR-21 ...
Read more...
Blogsphere:
Technorati
Feedster
Bloglines
Bookmark:
Del.icio.us
Spurl
Furl
Simpy
Blink
Digg